{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:01:57Z","timestamp":1774861317605,"version":"3.50.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejso.2024.108403","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T03:35:42Z","timestamp":1715139342000},"page":"108403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sarcopenia in gynaecological cancers"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4905-6948","authenticated-orcid":false,"given":"Riccardo","family":"Di Fiore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Drago-Ferrante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0530-6650","authenticated-orcid":false,"given":"Sherif","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6788-6040","authenticated-orcid":false,"given":"Francesco","family":"Pegreffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-0297","authenticated-orcid":false,"given":"Jean","family":"Calleja-Agius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/2278-330X.187575","article-title":"Gynecological cancers: a summary of published Indian data","volume":"5","author":"Maheshwari","year":"2016","journal-title":"South Asian J Cancer"},{"key":"10.1016\/j.ejso.2024.108403_bib2","series-title":"Interdisciplinary cancer research","article-title":"CD133 as biomarker and therapeutic target in gynecologic malignancies","author":"Di","year":"2023"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3892\/ol.2021.12594","article-title":"Role of MALAT1 in gynecological cancers: pathologic and therapeutic aspects","volume":"21","author":"Qiao","year":"2021","journal-title":"Oncol Lett"},{"issue":"7","key":"10.1016\/j.ejso.2024.108403_bib4","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1007\/s13277-015-3544-6","article-title":"EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects","volume":"36","author":"Liu","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ejso.2024.108403_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fonc.2014.00012","article-title":"Overexpression of cancer-associated genes via epigenetic derepression mechanisms in gynecologic cancer","volume":"4","author":"Jeong","year":"2014","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/cancers13030493","article-title":"GYNOCARE update: modern strategies to improve diagnosis and treatment of rare gynecologic tumors\u2014current challenges and future directions","volume":"13","author":"Di Fiore","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.ejso.2024.108403_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2024.108403_bib9","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Prim"},{"issue":"7203","key":"10.1016\/j.ejso.2024.108403_bib10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ejso.2024.108403_bib11","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2024.108403_bib12","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/bjs.9258","article-title":"Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma","volume":"100","author":"Harimoto","year":"2013","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.ejso.2024.108403_bib13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/dote.12381","article-title":"Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma","volume":"29","author":"Harada","year":"2016","journal-title":"Dis Esophagus"},{"issue":"5","key":"10.1016\/j.ejso.2024.108403_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jcsm.12115","article-title":"Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"7","author":"Go","year":"2016","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib15","first-page":"26","article-title":"Prognostic significance of sarcopenia in patients with metastatic renal cell carcinoma","volume":"195","author":"Fukushima","year":"2016","journal-title":"J\u00a0Urol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.smhs.2020.10.001","article-title":"Sarcopenia: clinical implications in ovarian cancer, diagnosis, etiology, and management","volume":"2","author":"Seol","year":"2020","journal-title":"Sports Med Health Sci"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/jhn.12649","article-title":"Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy","volume":"32","author":"S\u00e1nchez","year":"2019","journal-title":"J\u00a0Hum Nutr Diet"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1245\/s10434-014-4040-8","article-title":"Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer","volume":"22","author":"Kuroki","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/IGC.0000000000000867","article-title":"Sarcopenia in advanced serous ovarian cancer","volume":"27","author":"Bronger","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2024.108403_bib20","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/0008-5472.CAN-17-3287","article-title":"The importance of body composition in explaining the overweight paradox in cancer-counterpoint","volume":"78","author":"Caan","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2024.108403_bib21","doi-asserted-by":"crossref","first-page":"j477","DOI":"10.1136\/bmj.j477","article-title":"Adiposity and cancer at major anatomical sites: umbrella review of the literature","volume":"356","author":"Kyrgiou","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jcsm.12525","article-title":"Nutrition interventions to treat low muscle mass in cancer","volume":"11","author":"Prado","year":"2020","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"5 Suppl","key":"10.1016\/j.ejso.2024.108403_bib23","first-page":"990S","article-title":"Sarcopenia: origins and clinical relevance","volume":"127","author":"Rosenberg","year":"1997","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.ejso.2024.108403_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/epirev\/mxs006","article-title":"Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons","volume":"35","author":"Schaap","year":"2013","journal-title":"Epidemiol Rev"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jcsm.12048","article-title":"SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes","volume":"7","author":"Malmstrom","year":"2016","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"5","key":"10.1016\/j.ejso.2024.108403_bib27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in asia: consensus report of the asian working group for sarcopenia","volume":"15","author":"Chen","year":"2014","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"8","key":"10.1016\/j.ejso.2024.108403_bib30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jamda.2016.06.001","article-title":"Sarcopenia is recognized as an independent condition by an international classification of disease, tenth revision, clinical modification (ICD-10-CM) code","volume":"17","author":"Cao","year":"2016","journal-title":"J\u00a0Am Med Dir Assoc"},{"issue":"5","key":"10.1016\/j.ejso.2024.108403_bib31","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jcsm.12483","article-title":"Sarcopenia: a time for action. An scwd position paper","volume":"10","author":"Bauer","year":"2019","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis","volume":"13","author":"Petermann-Rocha","year":"2022","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0029665115002037","article-title":"Ageing well: a review of sarcopenia and frailty","volume":"74","author":"Keevil","year":"2015","journal-title":"Proc Nutr Soc"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/nu13030761","article-title":"Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer","volume":"13","author":"Meza-Valderrama","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12877-016-0349-4","article-title":"Sarcopenia in daily practice: assessment and management","volume":"16","author":"Beaudart","year":"2016","journal-title":"BMC Geriatr"},{"issue":"5","key":"10.1016\/j.ejso.2024.108403_bib36","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A\u00a0practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metabol"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/cancers12030559","article-title":"Impact of CT-determined sarcopenia and body composition on survival outcome in patients with advanced-stage high-grade serous ovarian carcinoma","volume":"12","author":"Kim","year":"2020","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.ejso.2024.108403_bib38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/hepr.12774","article-title":"Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): recommendation from the working group for creation of sarcopenia assessment criteria","volume":"46","author":"Nishikawa","year":"2016","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jcsm.12276","article-title":"Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation","volume":"9","author":"Hamaguchi","year":"2018","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejso.2024.108403_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2021.111227","article-title":"Use of artificial intelligence in the imaging of sarcopenia: a narrative review of current status and perspectives","volume":"89","author":"Rozynek","year":"2021","journal-title":"Nutrition"},{"key":"10.1016\/j.ejso.2024.108403_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1819841","article-title":"The value of artificial intelligence-assisted imaging in identifying diagnostic markers of sarcopenia in patients with cancer","volume":"2022","author":"Huang","year":"2022","journal-title":"Dis Markers"},{"issue":"5","key":"10.1016\/j.ejso.2024.108403_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037563","article-title":"Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma","volume":"7","author":"Mir","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib43","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10637-013-0053-6","article-title":"Low skeletal muscle is associated with toxicity in patients included in phase I trials","volume":"32","author":"Cousin","year":"2014","journal-title":"Invest N Drugs"},{"issue":"10","key":"10.1016\/j.ejso.2024.108403_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140403","article-title":"Skeletal muscle depletion and markers for cancer cachexia are strong prognostic factors in epithelial ovarian cancer","volume":"10","author":"Aust","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ejso.2024.108403_bib45","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ageing\/afu115","article-title":"Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)","volume":"43","author":"Cruz-Jentoft","year":"2014","journal-title":"Age Ageing"},{"issue":"18","key":"10.1016\/j.ejso.2024.108403_bib46","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.3390\/ijms22189724","article-title":"Sarcopenia: etiology, nutritional approaches, and miRNAs","volume":"22","author":"Cannataro","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib47","first-page":"1532","article-title":"Prevalence of sarcopenia in knee osteoarthritis: a systematic review and meta-analysis","volume":"12","author":"Pegreffi","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cger.2011.03.003","article-title":"Sarcopenia: origins and clinical relevance","volume":"27","author":"Rosenberg","year":"2011","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jcsm.12238","article-title":"Skeletal muscle performance and ageing","volume":"9","author":"Tieland","year":"2018","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cger.2016.08.002","article-title":"Pathogenesis and management of sarcopenia","volume":"33","author":"Dhillon","year":"2017","journal-title":"Clin Geriatr Med"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10522-008-9131-0","article-title":"Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness","volume":"9","author":"Ryall","year":"2008","journal-title":"Biogerontology"},{"issue":"6","key":"10.1016\/j.ejso.2024.108403_bib52","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3390\/biomedicines11061635","article-title":"Pathogenesis, intervention, and current status of drug development for sarcopenia: a review","volume":"11","author":"Jang","year":"2023","journal-title":"Biomedicines"},{"issue":"13","key":"10.1016\/j.ejso.2024.108403_bib53","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2174\/1381612821666150130122032","article-title":"Treating sarcopenia in older and oldest old","volume":"21","author":"Martone","year":"2015","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.ejso.2024.108403_bib54","article-title":"Clinical screening tools for sarcopenia and its management","volume":"2016","author":"Yu","year":"2016","journal-title":"Curr Gerontol Geriatr Res"},{"issue":"6","key":"10.1016\/j.ejso.2024.108403_bib55","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.clnu.2014.04.007","article-title":"Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group","volume":"33","author":"Deutz","year":"2014","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4235\/agmr.19.0028","article-title":"Pharmacological interventions for treatment of sarcopenia: current status of drug development for sarcopenia","volume":"23","author":"Kwak","year":"2019","journal-title":"Ann Geriatr Med Res"},{"key":"10.1016\/j.ejso.2024.108403_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tipsro.2020.10.001","article-title":"Sarcopenia in cancer: risking more than muscle loss","volume":"16","author":"Anjanappa","year":"2020","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib58","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1017\/S002966511500419X","article-title":"Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later","volume":"75","author":"Ryan","year":"2016","journal-title":"Proc Nutr Soc"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib59","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.clnu.2017.07.010","article-title":"Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review","volume":"37","author":"Pamoukdjian","year":"2018","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib60","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.ejso.2024.108403_bib61","article-title":"Female genital tumors","volume":"vol. 4","year":"2020"},{"issue":"10","key":"10.1016\/j.ejso.2024.108403_bib62","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.5858\/arpa.2018-0285-RS","article-title":"Borderline brenner tumor: a review of the literature","volume":"143","author":"Zheng","year":"2019","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib63","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib64","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"Ca - Cancer J Clin"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib65","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejso.2016.12.016","article-title":"The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery","volume":"43","author":"Rutten","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2024.108403_bib66","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1245\/s10434-018-6683-3","article-title":"Skeletal muscle attenuation (sarcopenia) predicts reduced overall survival in patients with advanced epithelial ovarian cancer undergoing primary debulking surgery","volume":"25","author":"Ataseven","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2024.108403_bib67","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/jso.24990","article-title":"Pre-operative core muscle index in combination with hypoalbuminemia is associated with poor prognosis in advanced ovarian cancer","volume":"117","author":"Conrad","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib68","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ygyno.2018.03.044","article-title":"Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: correlation with the extent of cytoreduction and complications","volume":"149","author":"Uccella","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108403_bib69","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jcsm.12468","article-title":"Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis","volume":"10","author":"Ubachs","year":"2019","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib70","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ygyno.2020.09.042","article-title":"No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study","volume":"159","author":"Ubachs","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib71","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ygyno.2020.01.003","article-title":"Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy","volume":"156","author":"Staley","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/diagnostics9040206","article-title":"Sarcopenic factors may have No impact on outcomes in ovarian cancer patients","volume":"9","author":"Nakayama","year":"2019","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib73","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jcsm.12524","article-title":"Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer","volume":"11","author":"Huang","year":"2020","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejso.2024.108403_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2019.110642","article-title":"Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer","volume":"72","author":"Huang","year":"2020","journal-title":"Nutrition"},{"key":"10.1016\/j.ejso.2024.108403_bib75","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/ijgc-2022-003387","article-title":"Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer","volume":"32","author":"Polen-De","year":"2022","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2024.108403_bib76","first-page":"3184","article-title":"Effect of muscle loss but not fat loss during primary debulking surgery and chemotherapy on prognosis of patients with ovarian cancer","volume":"11","author":"Nakayama","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ejso.2024.108403_bib77","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/jog.14516","article-title":"Extreme skeletal muscle loss during induction chemotherapy is an independent predictor of poor survival in advanced epithelial ovarian cancer patients","volume":"46","author":"Yoshino","year":"2020","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib78","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jcsm.13175","article-title":"Low L3 skeletal muscle index associated with the clinicopathological characteristics and prognosis of ovarian cancer: a meta-analysis","volume":"14","author":"Jin","year":"2023","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"7","key":"10.1016\/j.ejso.2024.108403_bib79","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ejso.2022.02.024","article-title":"Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: a systematic review and meta-analysis","volume":"48","author":"Tranoulis","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"24","key":"10.1016\/j.ejso.2024.108403_bib80","first-page":"9409","article-title":"Does sarcopenia predict perioperative mortality in patients with advanced ovarian cancer?","volume":"26","author":"Can","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib81","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3892\/ol.2020.11754","article-title":"Cervical cancer in low and middle-income countries","volume":"20","author":"Hull","year":"2020","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib82","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri1260","article-title":"Prevention of cervical cancer through papillomavirus vaccination","volume":"4","author":"Frazer","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib83","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ijc.28666","article-title":"Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort","volume":"135","author":"Roura","year":"2014","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2024.108403_bib84","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.bjc.6604974","article-title":"Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries","volume":"100","author":"Louie","year":"2009","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2024.108403_bib85","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.7314\/APJCP.2015.16.9.3893","article-title":"Multiple sexual partners as a potential independent risk factor for cervical cancer: a meta-analysis of epidemiological studies","volume":"16","author":"Liu","year":"2015","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"5","key":"10.1016\/j.ejso.2024.108403_bib86","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.aogh.2015.08.026","article-title":"Global variation of human papillomavirus genotypes and selected genes involved in cervical malignancies","volume":"81","author":"Husain","year":"2015","journal-title":"Ann Glob Health"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib87","first-page":"3316","article-title":"Comprehensive gene and pathway analysis of cervical cancer progression","volume":"19","author":"Yi","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejso.2024.108403_bib88","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2046-4053-2-35","article-title":"Screening for cervical cancer: a systematic review and meta-analysis","volume":"2","author":"Peirson","year":"2013","journal-title":"Syst Rev"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib89","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2015.07.015","article-title":"Influence of treatment center and hospital volume on survival for locally advanced cervical cancer","volume":"139","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib90","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.21873\/anticanres.13331","article-title":"Lymphocyte-to-Monocyte ratio and prognostic nutritional index predict poor prognosis in patients on chemotherapy for unresectable pancreatic cancer","volume":"39","author":"Shimizu","year":"2019","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.ejso.2024.108403_bib91","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10147-019-01461-7","article-title":"Clinical significance of prognostic nutritional index (PNI) in malignant melanoma","volume":"24","author":"Mirili","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108403_bib92","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clnesp.2019.04.004","article-title":"Sarcopenia as an independent prognostic factor in patients with metastatic colorectal cancer: a retrospective evaluation","volume":"32","author":"da Cunha","year":"2019","journal-title":"Clin Nutr ESPEN"},{"issue":"10","key":"10.1016\/j.ejso.2024.108403_bib93","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.21873\/anticanres.12928","article-title":"Baseline sarcopenia and skeletal muscle loss during chemotherapy affect survival outcomes in metastatic gastric cancer","volume":"38","author":"Sugiyama","year":"2018","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib94","first-page":"450","article-title":"Association of sarcopenia with and efficacy of anti-PD-1\/PD-L1 therapy in non-small-cell lung cancer","volume":"8","author":"Nishioka","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"6","key":"10.1016\/j.ejso.2024.108403_bib95","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/ncp.10482","article-title":"Sarcopenia as a predictor of survival among patients with organ metastatic cervical cancer","volume":"35","author":"Yoshikawa","year":"2020","journal-title":"Nutr Clin Pract"},{"issue":"5","key":"10.1016\/j.ejso.2024.108403_bib96","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41430-020-00797-y","article-title":"Body composition and nutritional status according to clinical stage in patients with locally advanced cervical cancer","volume":"75","author":"Flores-Cisneros","year":"2021","journal-title":"Eur J Clin Nutr"},{"issue":"9","key":"10.1016\/j.ejso.2024.108403_bib97","first-page":"5497","article-title":"Association of bowel radiation dose-volume with skeletal muscle loss during pelvic intensity-modulated radiotherapy in cervical cancer","volume":"29","author":"Lee","year":"2021","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2024.108403_bib98","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1080\/01635581.2021.2012209","article-title":"Handgrip strength, overhydration and nutritional status as a predictors of gastrointestinal toxicity in cervical cancer patients. A prospective study","volume":"74","author":"Laura","year":"2022","journal-title":"Nutr Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2024.108403_bib99","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.21873\/anticanres.15994","article-title":"Sarcopenia is an independent prognostic factor for squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy","volume":"42","author":"Kise","year":"2022","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib100","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3390\/cancers12030595","article-title":"Muscle loss after chemoradiotherapy as a biomarker of distant failures in locally advanced cervical cancer","volume":"12","author":"Lee","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.ejso.2024.108403_bib101","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10147-022-02140-w","article-title":"Extreme leanness, lower skeletal muscle quality, and loss of muscle mass during treatment are predictors of poor prognosis in cervical cancer treated with concurrent chemoradiation therapy","volume":"27","author":"Abe","year":"2022","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib102","doi-asserted-by":"crossref","first-page":"933","DOI":"10.21873\/anticanres.13196","article-title":"Sarcopenia is not a prognostic factor of outcome in patients with cervical cancer undergoing concurrent chemoradiotherapy or radiotherapy","volume":"39","author":"Matsuoka","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2024.108403_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.741071","article-title":"Impact of computed tomography-based, artificial intelligence-driven volumetric sarcopenia on survival outcomes in early cervical cancer","volume":"11","author":"Han","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejso.2024.108403_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111966","article-title":"Low skeletal muscle mass predicts poor prognosis for patients with stage III cervical cancer on concurrent chemoradiotherapy","volume":"109","author":"Aichi","year":"2023","journal-title":"Nutrition"},{"key":"10.1016\/j.ejso.2024.108403_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1113588","article-title":"Development and validation of a radiomics-based nomogram for the prediction of postoperative malnutrition in stage IB1-IIA2 cervical carcinoma","volume":"10","author":"Yu","year":"2023","journal-title":"Front Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2024.108403_bib106","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/PGP.0000000000000552","article-title":"Endometrial carcinoma, grossing and processing issues: recommendations of the international society of gynecologic pathologists","volume":"38","author":"Malpica","year":"2019","journal-title":"Int J Gynecol Pathol"},{"issue":"15","key":"10.1016\/j.ejso.2024.108403_bib107","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.3390\/ijms22157829","article-title":"LncRNA MORT (ZNF667-AS1) in cancer-is there a possible role in gynecological malignancies?","volume":"22","author":"Di Fiore","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.ejso.2024.108403_bib108","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.3390\/cancers13092149","article-title":"A\u00a0narrative review of the role of diet and lifestyle factors in the development and prevention of endometrial cancer","volume":"13","author":"Yasin","year":"2021","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.ejso.2024.108403_bib109","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial cancer","volume":"383","author":"Lu","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ejso.2024.108403_bib110","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3390\/cancers13102434","article-title":"Predictive and prognostic value of microsatellite instability in gynecologic cancer (endometrial and ovarian)","volume":"13","author":"Evrard","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ejso.2024.108403_bib111","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00428-003-0947-3","article-title":"Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification","volume":"444","author":"Lax","year":"2004","journal-title":"Virchows Arch"},{"issue":"10023","key":"10.1016\/j.ejso.2024.108403_bib112","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","article-title":"Endometrial cancer","volume":"387","author":"Morice","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib113","doi-asserted-by":"crossref","first-page":"153","DOI":"10.6004\/jnccn.2017.7028","article-title":"Skeletal muscle quality beyond average muscle attenuation: a proposal of skeletal muscle phenotypes to predict short-term survival in patients with endometrial cancer","volume":"16","author":"Rodrigues","year":"2018","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib114","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/jcsm.12440","article-title":"Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer","volume":"10","author":"Lee","year":"2019","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/1754-9485.12935","article-title":"The impact of skeletal muscle abnormalities on tolerance to adjuvant chemotherapy and radiation and outcome in patients with endometrial cancer","volume":"64","author":"Ganju","year":"2020","journal-title":"J\u00a0Med Imaging Radiat Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2024.108403_bib116","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41430-022-01085-7","article-title":"Pre-treatment sarcopenic assessments as a prognostic factor for gynaecology cancer outcomes: systematic review and meta-analysis","volume":"76","author":"Sutton","year":"2022","journal-title":"Eur J Clin Nutr"},{"issue":"4","key":"10.1016\/j.ejso.2024.108403_bib117","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41430-018-0163-5","article-title":"Comparison of the prognostic value of different skeletal muscle radiodensity parameters in endometrial cancer","volume":"73","author":"de Paula","year":"2019","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.ejso.2024.108403_bib118","article-title":"Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab","volume":"30","author":"Gillen","year":"2019","journal-title":"Gynecol Oncol Rep"},{"issue":"2","key":"10.1016\/j.ejso.2024.108403_bib119","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ijgo.13591","article-title":"The role of sarcopenic obesity in high-grade endometrial cancer","volume":"154","author":"Donkers","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"issue":"12","key":"10.1016\/j.ejso.2024.108403_bib120","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1590\/1806-9282.20210364","article-title":"Clinical implication of preoperative psoas muscle area in endometrial cancer patients","volume":"67","author":"Bilir","year":"2021","journal-title":"Rev Assoc Med Bras"},{"issue":"1","key":"10.1016\/j.ejso.2024.108403_bib121","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13244-021-01134-y","article-title":"Prognostic role of computed tomography-based, artificial intelligence-driven waist skeletal muscle volume in uterine endometrial carcinoma","volume":"12","author":"Kim","year":"2021","journal-title":"Insights Imaging"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324004554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324004554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:13:28Z","timestamp":1774858408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324004554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0748798324004554"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108403","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcopenia in gynaecological cancers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108403"}}